Natural Compounds Targeting Thymic Stromal Lymphopoietin (TSLP): A Promising Therapeutic Strategy for Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease with rising prevalence, marked by eczematous lesions, itching, and a weakened skin barrier often tied to filaggrin gene mutations. This breakdown allows allergen and microbe entry, with thymic stromal lymphopoietin (TSLP) playing a crucia...
Saved in:
| Main Authors: | Muhammad Suleman, Chiara Moltrasio, Paola Maura Tricarico, Angelo Valerio Marzano, Sergio Crovella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/12/1521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indole-3-carbinol alleviates allergic skin inflammation via periostin/thymic stromal lymphopoietin suppression in atopic dermatitis
by: Yun-Mi Kang, et al.
Published: (2024-12-01) -
Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases
by: Partho Protim Adhikary, et al.
Published: (2024-06-01) -
A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases
by: Lihua Shi, et al.
Published: (2024-12-01) -
Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01) -
Update Management of Atopic Dermatitis
by: Indri Widya Sari, et al.
Published: (2024-11-01)